Life Sciences
As government reform efforts converge, significant FDA staff cuts are likely
Feb 10, 2025
Read More >>
Boost Your Regulatory IQ
Simplify the complex with customized blog posts on life sciences and chemical regulation from AgencyIQ. We bring daily updates and analysis on the things that matter to you—helping you get smarter about regulation on the horizon and your next course of action.
Life Sciences
Analysis: The majority of novel drugs approved by FDA rely on evidence from a single pivotal trial
Feb 07, 2025
Read More >>Life Sciences
FDA updates guidance language, forms to align with Trump executive order
Feb 03, 2025
Read More >>
Life Sciences
Status check: What’s going on with FDA’s diversity-related policies
Jan 30, 2025
Read More >>Life Sciences
The 176 guidance documents that FDA is currently working on affecting the life sciences industry
Jan 29, 2025
Read More >>Life Sciences
FDA pulls diversity action plan guidance, other diversity programs after executive order
Jan 23, 2025
Read More >>Life Sciences
In two new documents, FDA offers developers guidance on assessing sex-based differences
Jan 13, 2025
Read More >>Life Sciences
What CDER Director Patrizia Cavazzoni’s retirement means for FDA
Jan 10, 2025
Read More >>Get an insider’s view on regulatory movements.
Sign up for AgencyIQ’s newsletters to receive exclusive regulatory updates and analysis impacting the life sciences or chemical industry.